Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line
“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.
You may also be interested in...
Dietary supplement brands with sustainable and ethical credentials are expected to be popular M&A targets for consumer health firms in 2024, but macroeconomic conditions will likely keep overall deal activity relatively low.
P&G announces Clearblue Menopause Stage Indicator launch noting more than two in three women feel unprepared for menopause and less than half say they have enough information to manage it. Kenvue survey results show prior to age 50, proportion of women experiencing symptoms attributable to menopause is significantly greater than the proportion that self-reports.
Women’s health company acquired patent for SAM-e formulation MSI-195 after innovator's study showed it had nearly three times higher availability than a leading competitor.